TherOx has had a withdrawn IPO, snub from the FDA, but looks like it's rebounding with its promising device that could help salvage damaged heart tissue after a heart attack.
TherOx, an Irvine, Calif.-based medical device company, seeks $25 million for the final push to bring its treatment to increase the quality of life for heart attack patients. The company’s optimized “super-saturated oxygen” (SSO2) offers a solution to reduce infarct size by increasing oxygen to heart tissue damaged during percutaneous coronary intervention and stenting. Following an FDA […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Venture capital is highly competitive in the medical devices industry. Some VCs are even moving out of the device and healthcare space. But, in many cases, venture capital really still is the best kind of equity investment to be had in the medical device industry. If you have a high-risk, PMA-route device, a true innovation, […]